| Second unrelated donor hematopoietic cell transplantation for primary graft failure J Schriber, MA Agovi, V Ho, KK Ballen, A Bacigalupo, HM Lazarus, ... Biology of Blood and Marrow Transplantation 16 (8), 1099-1106, 2010 | 97 | 2010 |
| Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide CN Bredeson, MJ Zhang, MA Agovi, A Bacigalupo, NJ Bahlis, K Ballen, ... Biology of Blood and Marrow Transplantation 14 (9), 993-1003, 2008 | 97 | 2008 |
| Effects of spleen status on early outcomes after hematopoietic cell transplantation G Akpek, MC Pasquini, B Logan, MA Agovi, HM Lazarus, DI Marks, ... Bone marrow transplantation 48 (6), 825-831, 2013 | 85 | 2013 |
| Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults WH Navarro, MA Agovi, BR Logan, K Ballen, BJ Bolwell, H Frangoul, ... Biology of Blood and Marrow Transplantation 16 (10), 1442-1450, 2010 | 82 | 2010 |
| Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia JP Uberti, MA Agovi, S Tarima, M Haagenson, S Gandham, C Anasetti, ... Bone marrow transplantation 46 (1), 34-43, 2011 | 40 | 2011 |
| Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation DH McDermott, SE Conway, T Wang, SM Ricklefs, MA Agovi, SF Porcella, ... Blood, The Journal of the American Society of Hematology 115 (11), 2311-2318, 2010 | 38 | 2010 |
| Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia CC Barker, MA Agovi, B Logan, HM Lazarus, KK Ballen, V Gupta, ... Biology of Blood and Marrow Transplantation 17 (5), 737-744, 2011 | 29 | 2011 |
| High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma PJ Stiff, MA Agovi, KH Antman, D Blaise, BM Camitta, MS Cairo, ... Biology of Blood and Marrow Transplantation 16 (4), 525-532, 2010 | 17 | 2010 |
| Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system AMA Agovi, I Anikpo, MJ Cvitanovich, KJ Craten, EO Asuelime, RP Ojha Preventive medicine reports 20, 101266, 2020 | 14 | 2020 |
| The blood and marrow transplant clinical trials network: an effective infrastructure for addressing important issues in hematopoietic cell transplantation SC of the Blood, MTCT Network Biology of Blood and Marrow Transplantation 22 (10), 1747-1757, 2016 | 10 | 2016 |
| The data‐collection on adverse effects of anti‐HIV drugs (D: A: D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV I Anikpo, AMA Agovi, MJ Cvitanovich, F Lonergan, M Johnson, RP Ojha HIV medicine 22 (10), 936-943, 2021 | 6 | 2021 |
| Allogeneic hematopoietic cell transplantation (AHCT) for primary cutaneous T cell lymphoma (CTCL): a Center for International Blood and Marrow Transplant Research (CIBMTR) review MJ Lechowicz, M Agovi, J Carreras, HM Lazarus, GG Laport, S Montoto, ... Blood, The Journal of the American Society of Hematology 116 (21), 364-364, 2010 | 5 | 2010 |
| How close to 90–90-90? Measuring undiagnosed HIV infection, ART use and viral suppression in a community-based sample from Namibia’s highest prevalence region T Nakanyala, S Patel, S Sawadogo, A Maher, K Banda, A Wolkon, ... 21st International AIDS Conference Durban, 2016 | 2 | 2016 |
| Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT). G Akpek, MC Pasquini, MA Agovi, B Logan, KR Cooke, RT Maziarz, ... Blood 116 (21), 3486, 2010 | 2 | 2010 |
| Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?. J Horan, BR Logan, MA Agovi, HM Lazarus, A Bacigalupo, K Ballen, ... Blood 114 (22), 649, 2009 | 2 | 2009 |
| Brief report: HIV Pre-exposure prophylaxis prescribing in an urban safety-net health system AMA Agovi, I Anikpo, MJ Cvitanovich, EO Fasanmi, RP Ojha, JL Marcus JAIDS Journal of Acquired Immune Deficiency Syndromes 88 (3), e17-e21, 2021 | 1 | 2021 |
| Rates and Correlates of HIV Incidence in Namibia’s Zambezi Region From 2014 to 2016: Sentinel, Community-Based Cohort Study AD Maher, T Nakanyala, N Mutenda, KM Banda, D Prybylski, A Wolkon, ... JMIR Public Health and Surveillance 6 (2), e17107, 2020 | 1 | 2020 |
| Sociodemographic and health-related characteristics of a safety-net patient population AMA Agovi, I Anikpo, MJ Cvitanovich, L Yan, TC Chu, B MacDonald, ... | 1 | 2019 |
| Hepatitis B, C virus and HIV co-infection among reported female cases in South Carolina, 2004-2011: An epidemiological analysis of pregnancy outcomes AMA Agovi University of South Carolina, 2014 | 1 | 2014 |
| Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) in adults WH Navarro, MA Agovi, B Logan, A Bacigalupo, KK Ballen, BJ Bolwell, ... Blood, The Journal of the American Society of Hematology 112 (11), 51-51, 2008 | 1 | 2008 |
